Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip van den Bosch

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Arthritis Care & Research|September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisMichael M Ward, Atul Deodhar, Elie A Akl, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trialRobert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisMichael M Ward, Atul Deodhar, Elie A Akl, et al.
Annals of the Rheumatic Diseases|March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 updatePeter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Annals of the Rheumatic Diseases|July 6, 2026
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS projectSofia Ramiro, Dafne Capelusnik, Clementina López-Medina, et al.
The Journal of Rheumatology|January 15, 2025
Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile SpondyloarthritisAdam Mayer, Timothy G Brandon, Amita Aggarwal, et al.
Annals of the Rheumatic Diseases|February 15, 2025
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial SpondyloarthritisDenis Poddubnyy, Victoria Navarro-Compán, Murat Torgutalp, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Arthritis Care & Research|September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisMichael M Ward, Atul Deodhar, Elie A Akl, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trialRobert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisMichael M Ward, Atul Deodhar, Elie A Akl, et al.
Annals of the Rheumatic Diseases|March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 updatePeter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Annals of the Rheumatic Diseases|July 6, 2026
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS projectSofia Ramiro, Dafne Capelusnik, Clementina López-Medina, et al.
The Journal of Rheumatology|January 15, 2025
Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile SpondyloarthritisAdam Mayer, Timothy G Brandon, Amita Aggarwal, et al.
Annals of the Rheumatic Diseases|February 15, 2025
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial SpondyloarthritisDenis Poddubnyy, Victoria Navarro-Compán, Murat Torgutalp, et al.
Pageof 20